Session » Osteoarthritis – Clinical Poster

Date: Monday, November 14, 2022

Time: 1:00PM-3:00PM

Meeting: ACR Convergence 2022

1:00PM-3:00PM: Abstract Number: 1894

A Phase 2, 104-Week Study of Repeat Lorecivivint Injections Evaluating Safety, Efficacy, and Bone Health Utilizing Quantitative Computed Tomography (qCT) in Knee Osteoarthritis (OA-06)

1:00PM-3:00PM: Abstract Number: 1899

A Phase 3, 28-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (OA-10) to Evaluate the Efficacy and Safety of a Single Injection of Lorecivivint Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects

1:00PM-3:00PM: Abstract Number: 1897

A Preliminary Estimate of Objectively Measured Sedentary Behavior in Knee Osteoarthritis

1:00PM-3:00PM: Abstract Number: 1917

A Remote Behaviorally-Designed Intervention to Promote Physical Activity in Patients with Knee Osteoarthritis: Results of a Pilot Randomized Clinical Trial

1:00PM-3:00PM: Abstract Number: 1914

Acoustic Classification of Early and Advanced Osteoarthritis of the Knee in Clinical Settings

1:00PM-3:00PM: Abstract Number: 1896

Alkylresorcinol, a Biomarker for Whole Grain Intake, and Its Association with Osteoarthritis: The MOST Study

1:00PM-3:00PM: Abstract Number: 1893

Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of Two Phase 3 Clinical Trials

1:00PM-3:00PM: Abstract Number: 1921

Association Between Knee Osteoarthritis and Health-Related Quality of Life in Persons with Type 2 Diabetes

1:00PM-3:00PM: Abstract Number: 1895

Association Between Synovial Tissue Metabolomic Profile and Pain in Patients with Knee Osteoarthritis

1:00PM-3:00PM: Abstract Number: 1912

Associations of Nociceptive Dysfunction with Physical Activity in Knee Osteoarthritis: The Multicenter Osteoarthritis Study

1:00PM-3:00PM: Abstract Number: 1911

Baseline Bone Curvature a Biomarker for the Prediction of Knee Osteoarthritis Cartilage Volume Loss at One-Year. Use of Machine Learning

1:00PM-3:00PM: Abstract Number: 1906

Bile Acid Profile Is Associated to Synovitis in Knee Osteoarthritis

1:00PM-3:00PM: Abstract Number: 1923

Co-fluctuations of Knee Pain Between Knees in the Same Person: Data from the Osteoarthritis Initiative (OAI)

1:00PM-3:00PM: Abstract Number: 1900

CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK)-A Double-blind, Placebo-controlled Trial

1:00PM-3:00PM: Abstract Number: 1909

Corticosteroids with or Without Hyaluronic Acid Injections in the Treatment of Trapeziometacarpal (TMC) Osteoarthritis : The Randomised Multicentre RHIZ’ART Trial Study Protocol

1:00PM-3:00PM: Abstract Number: 1916

Defining Early-stage Knee Osteoarthritis: A Scoping Review

1:00PM-3:00PM: Abstract Number: 1915

Development of an MRI-based Definition of Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study

1:00PM-3:00PM: Abstract Number: 1905

Does Exercise Before Surgery Predict Trajectories of Physical Activity After Knee Replacement?

1:00PM-3:00PM: Abstract Number: 1903

Does Pain Sensitization by Pressure Pain Thresholds and Temporal Summation Predict Persistent Pain in Persons with Hand OA?

1:00PM-3:00PM: Abstract Number: 1910

Evaluation of Dynamic Effects of Depressive Symptoms on Functional Outcomes in Knee Osteoarthritis

1:00PM-3:00PM: Abstract Number: 1920

Gait and Physical Activity Predictors of Knee Replacement: A Machine Learning Analysis in the Multicenter Osteoarthritis Study

1:00PM-3:00PM: Abstract Number: 1892

Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis: A Randomised Double-blind Placebo Controlled Trial

1:00PM-3:00PM: Abstract Number: 1889

Investigating a Possible Bi-Directional Causal Relationship Between Gout and Osteoarthritis for the European Population: Two-Sampled Mendelian Randomization Analysis Study

1:00PM-3:00PM: Abstract Number: 1904

Is Treating Painful Hand Osteoarthritis with Hormone Replacement Therapy Feasible? Primary Results from a Randomised Controlled Trial in Post-menopausal Women

1:00PM-3:00PM: Abstract Number: 1922

Multi-Joint Osteoarthritis Phenotypes by Race/Ethnicity and Sex: Preliminary Descriptive Data from the Johnston County Health Study

1:00PM-3:00PM: Abstract Number: 1918

Neurobiological Mechanisms of a Remote-Delivered Mind-body Intervention for Knee Osteoarthritis

1:00PM-3:00PM: Abstract Number: 1888

Novel Small Molecule Modulator of the gp130 Receptor Shows Dose-dependent Therapeutic Efficacy in a Canine Model of Osteoarthritis

1:00PM-3:00PM: Abstract Number: 1891

Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab: A Randomized Placebo-Controlled Trial

1:00PM-3:00PM: Abstract Number: 1898

Radiographic Osteoarthritis Progression Can Be Predicted via Pyrosequencing Analysis of Baseline Peripheral Blood

1:00PM-3:00PM: Abstract Number: 1908

Should Osteoarthritis Patients with Pain Scores More Than 8/10 Be Analyzed Separately or Excluded from Clinical Trial Protocols, as 72% Screen Positive for Fibromyalgia And/or Depression on a Multidimensional Health Assessment Questionnaire (MDHAQ)?

1:00PM-3:00PM: Abstract Number: 1907

Strength Training Associates with Less Knee Osteoarthritis: Data from the Osteoarthritis Initiative

1:00PM-3:00PM: Abstract Number: 1902

Structural Severity in Knee Osteoarthritis Impacts Treatment Response: A Post Hoc Pooled Analysis of Lorecivivint Clinical Trials

1:00PM-3:00PM: Abstract Number: 1913

The Association of Radiographic Chondrocalcinosis with Localized Structural Outcomes in Knee OA: The Multicenter Osteoarthritis Study

1:00PM-3:00PM: Abstract Number: 1890

The Efficacy of Intra-articular Triamcinolone Acetonide 10 mg vs. 40 mg in Patients with Knee Osteoarthritis: a Non-inferiority, Randomized, Controlled, Double-blind, Multicenter Study

1:00PM-3:00PM: Abstract Number: 1919

Underdiagnosis and Undertreatment of Knee Osteoarthritis in Persons with Type 2 Diabetes: A Cross-sectional Study

1:00PM-3:00PM: Abstract Number: 1901

What Does Radiographic Minimum JSW Actually Measure? Comparison of Radiographic and MRI Measures Using Data from the OAI

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].